Thoratec Scouting Cardiac Cell Delivery Catheter Applications For LVAD
This article was originally published in The Gray Sheet
Executive Summary
Thoratec's equity investment in BioCardia reflects the firm's desire to explore combination therapies in anticipation of future heart failure trends